The effect of 24,25 dihydroxyvitamin D3 on calcium efflux: The role of protein kinase C

Nephrology

Volumn 4, Issue 3, 1998, Pages 157-162

  Dranitzki Elhalel, Michal ^a   Wald, Hanna ^a   Sprague, Stuart ^a,b   Popovtzer, Mordecai M ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b EVANSTON HOSPITAL   (United States)

Author keywords

24,25(OH)2D3; Bone; Calcium flux; Cyclic AMP; Metabolism; Protein kinase C

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; CALCIUM; CYCLIC AMP; PARATHYROID HORMONE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; STAUROSPORINE;

ANIMAL TISSUE; ARTICLE; BONE METABOLISM; BONE MINERALIZATION; CALCIUM TRANSPORT; CALVARIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; KIDNEY FAILURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0031881059     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.1998.d01-26.x     Document Type: Article

References (32)

1. 3 metabolite biologically active in cartilage. FEBS 1980; 80: 273-6.
2. 3. Bone 1992; 92: 229-36.
3. 3 receptor in the parathyroid gland of the rachitic chick. Biochem.. Biophys. Res. Comm. 1981; 81: 551-8.
4. 3 on bone remodeling. Calcif. Tissue Int. 1980; 80: 209-13.
5. Kanis JA, Cundy T, Bartlett M et al. Is 24,25-dihdyroxycholecalciferol a calcium-regulating hormone in man? Br. Med. J. 1978; 78: 1382-6.
6. 3 metabolites on rat calvaria cAMP content. Calcif. Tissue Int. 1980; 80: 209-16.
7. 3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats. Calcif. Tissue Int. 1990; 90: 339-45.
8. 3. Calcif. Tissue Int. 1988; 88: 235-43.
9. Ornoy A, Goodwin D, Noff P, Edelstein S. 24,25-dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation. Nature 1978; 78: 517-9.
10. 3 in osteoclasts. Proc. Soc. Exp. Biol. Med. 1992; 92: 161-4.
11. 3 in predialysis renal insufficiency: Biochemistry and histomorphometry of cancellous bone. J. Bone Miner. Metab. 1995; 95: 197-204.
12. 3. Clin. Nephrol. 1985; 85: 292-9.
13. 3 alone or in combination. Min. Electrol. Metab. 1985; 85: 358-68.
14. 3 therapy for bone disease in dialysis patients. Bone 1992; 92: 369-77.
15. Canterbury JM, Gavellas G, Bourgeoignie JJ, Reiss E. Metabolic consequences of oral administration of 24,25-dihydroxycholecalciferol to uremic dogs. J. Am. Soc. Clin. Invest. 1980; 80: 561-76.
16. 3(24, 25D) ameliorates high-turnover related osteopenia and increases bone mass in uremic rats. J. Amer. Soc. Nephrol. 1995; 6: 936.
17. 3 ameliorates the high-turnover bone diseases without suppressing parathyroid function in chronic renal failure in rats. Nephrology 1996; 96: 361-6.
18. Pavlovitch JH, Cournot-Witmer G, Bourdeau A, Balsan S, Fischer JA, Eynen GH. Suppressive effects of 24,25-dihydroxycholecalciferol on bone resorption induced by acute bilateral nephrectomy in rats. J. Clin. Invest. 1981; 81: 803-10.
19. 3 in rats with reduced renal mass. Proc. Soc. Exp. Biol. Med. 1987; 87: 64-9.
20. 3 by mechanisms independent of intestinal calcium absorption. J. Bone Min. 1991; 91: 219-26.
21. 3 induced efflux of calcium from cultured calvaria is mediated by activation of protein kinase. C. J. Amer. Soc. Nephrol. 1994; 4, 891 (Abstract).
22. Bushinsky DA, Goldring JS, Coe FL. Cellular contribution to pH-mediated calcium flux in neonatal mouse calvariae. Am. J. Physiol. 1985; 85: F785-9.
23. Moe SM, Sprague SM. Beta-2-microglobulin induces calcium efflux from cultured neonatal mouse calvariae. Am. J. Physiol. 1992; 92: F540-5.
24. Sprague SM, Krieger N, Bushinsky DA. Aluminum inhibits formation of bone nodules in vitro. Am. J. Physiol. 1993; 93: F882-90.
25. Pfeilschifter J, Ochsner M, Whitebread S, de Gasparo M. Down-regulation of protein kinase C potentiates angiotensin II stimulated polyphospinositide hydrolysis in vascular smooth-muscle cells. Biochem. J. 1989; 89: 285-91.
26. Malmstrom K, Murer H. Parathyroid hormone inhibits phosphate transport in OK cells but not in ILC-PK and JTC 12.3 PC cells. Am. J. Physiol. 1986; 151: C23-31.
27. Teitelbaum AP, Strewler GJ. Parathyroid receptors coupled to cyclic nucleotide monophosphate formation in an established renal cell line. Endocrinology 1984; 84: 980-5.
28. Gilman AG. A protein-binding assay for adenosine 3′5′ cyclic monophosphate. Proc. Natl. Acad. Sci. (USA) 1970; 70: 305-12.
29. Friedlaender MM, Yagil Y, Wald H, Popovtzer MM. 22-oxacalcitriol does not interfere with parathyroid hormone-induced phosphaturia or cyclic AMP excretion. Bone 1995; 17: 301-6.
30. Sprague S, Wald H, Dranitzki-Elhalel M, Popovtzer M. Parathyroid hormone induced calcium efflux from cultured calvaria is protein kinase C dependent. Am. J. Physiol. 1996; 40: F1139-46.
31. 3 on the formation and function of osteoclastic cells. Calcif. Tissue Int. 1993; 93: 255-60.
32. Nagata N, Sasaki M, Kumura N, Nakane K. The hypercalcemic effect of parathyroid hormone and skeletal cyclic AMP. Endocrinology 1969; 69: 761-8.